Search

Search Constraints

You searched for: Author/Creator Weishaupt, Carsten

Search Results

11. Functional and molecular genetic analyses of nine newly identified XPD‐deficient patients reveal a novel mutation resulting in TTD as well as in XP/CS complex phenotypes. Issue 7 (25th June 2013)

12. Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG. Issue 1 (5th May 2020)

13. Impact of blood involvement on efficacy and time to response with mogamulizumab in mycosis fungoides and Sézary syndrome. (30th August 2022)

14. Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG. Issue 6 (10th June 2022)

15. Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma. (April 2017)

16. Low‐dose total skin electron beam therapy plus oral bexarotene maintenance therapy for cutaneous T‐cell lymphoma. (5th January 2022)

17. MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma – An evaluation of the multicenter prospective skin cancer registry ADOREG. (May 2022)

18. Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy. (June 2016)

19. Niedrig dosierte Ganzhautelektronenbestrahlung mit oraler Bexaroten‐Erhaltungstherapie beim kutanen T‐Zell‐Lymphom. (19th March 2022)

20. Outcome of melanoma patients with elevated LDH treated with first-line targeted therapy or PD-1-based immune checkpoint inhibition. (May 2021)